Literature DB >> 31229169

Caenorhabditis elegans and its applicability to studies on restless legs syndrome.

Pan Chen1, Omamuyovwi Meashack Ijomone2, Kun He Lee1, Michael Aschner3.   

Abstract

Restless legs syndrome (RLS) is a common neurological disorder in the United States. This disorder is characterized by an irresistible urge to move the legs, although the symptoms vary in a wide range. The pathobiology of RLS has been linked to iron (Fe) deficiency and dopaminergic (DAergic) dysfunction. Several genetic factors have been reported to increase the risk of RLS. Caenorhabditis elegans (C. elegans) is a well-established animal model with a fully sequenced genome, which is highly conserved with mammals. Given the detailed knowledge of its genomic architecture, ease of genetic manipulation and conserved biosynthetic and metabolic pathways, as well as its small size, ease of maintenance, speedy generation time and large brood size, C. elegans provides numerous advantages in studying RLS-associated gene-environment interactions. Here we will review current knowledge about RLS symptoms, pathology and treatments, and discuss the application of C. elegans in RLS study, including the worm homologous genes and methods that could be performed to advance the pathophysiology RLS.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C. elegans; Dopaminergic dysfunction; Iron deficiency; RLS; Restless legs syndrome

Mesh:

Substances:

Year:  2019        PMID: 31229169      PMCID: PMC6592618          DOI: 10.1016/bs.apha.2018.12.003

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


  129 in total

1.  KEL-8 is a substrate receptor for CUL3-dependent ubiquitin ligase that regulates synaptic glutamate receptor turnover.

Authors:  Henry Schaefer; Christopher Rongo
Journal:  Mol Biol Cell       Date:  2006-01-04       Impact factor: 4.138

2.  Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.

Authors:  Richard P Allen; Daniel L Picchietti; Diego Garcia-Borreguero; William G Ondo; Arthur S Walters; John W Winkelman; Marco Zucconi; Raffaele Ferri; Claudia Trenkwalder; Hochang B Lee
Journal:  Sleep Med       Date:  2014-05-17       Impact factor: 3.492

3.  FMRFamide-like FLP-13 neuropeptides promote quiescence following heat stress in Caenorhabditis elegans.

Authors:  Matthew D Nelson; Kun He Lee; Matthew A Churgin; Andrew J Hill; Cheryl Van Buskirk; Christopher Fang-Yen; David M Raizen
Journal:  Curr Biol       Date:  2014-09-25       Impact factor: 10.834

4.  Circadian rhythms in metabolic variables in Caenorhabditis elegans.

Authors:  María Laura Migliori; Sergio H Simonetta; Andrés Romanowski; Diego A Golombek
Journal:  Physiol Behav       Date:  2011-02-18

Review 5.  The restless legs syndrome.

Authors:  Claudia Trenkwalder; Walter Paulus; Arthur S Walters
Journal:  Lancet Neurol       Date:  2005-08       Impact factor: 44.182

6.  Gamma-aminobutyric acid (GABA) receptors genes polymorphisms and risk for restless legs syndrome.

Authors:  Félix Javier Jiménez-Jiménez; Gara Esguevillas; Hortensia Alonso-Navarro; Martín Zurdo; Laura Turpín-Fenoll; Jorge Millán-Pascual; Teresa Adeva-Bartolomé; Esther Cubo; Francisco Navacerrada; Gemma Amo; Ana Rojo-Sebastián; Lluisa Rubio; Mónica Díez-Fairén; Pau Pastor; Marisol Calleja; José Francisco Plaza-Nieto; Belén Pilo-de-la-Fuente; Margarita Arroyo-Solera; Esteban García-Albea; José A G Agúndez; Elena García-Martín
Journal:  Pharmacogenomics J       Date:  2018-05-03       Impact factor: 3.550

7.  MEK-2, a Caenorhabditis elegans MAP kinase kinase, functions in Ras-mediated vulval induction and other developmental events.

Authors:  Y Wu; M Han; K L Guan
Journal:  Genes Dev       Date:  1995-03-15       Impact factor: 11.361

8.  Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome.

Authors:  James R Connor; Xin-Sheng Wang; Richard P Allen; John L Beard; Jason A Wiesinger; Barbara T Felt; Christopher J Earley
Journal:  Brain       Date:  2009-05-25       Impact factor: 13.501

9.  Splicing-Dependent Trans-synaptic SALM3-LAR-RPTP Interactions Regulate Excitatory Synapse Development and Locomotion.

Authors:  Yan Li; Peng Zhang; Tae-Yong Choi; Sook Kyung Park; Hanwool Park; Eun-Jae Lee; Dongsoo Lee; Junyeop Daniel Roh; Won Mah; Ryunhee Kim; Yangsik Kim; Harah Kwon; Yong Chul Bae; Se-Young Choi; Ann Marie Craig; Eunjoon Kim
Journal:  Cell Rep       Date:  2015-08-28       Impact factor: 9.423

10.  Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Restless Legs Syndrome.

Authors:  Elena García-Martín; Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Carmen Martínez; Martín Zurdo; Laura Turpín-Fenoll; Jorge Millán-Pascual; Teresa Adeva-Bartolomé; Esther Cubo; Francisco Navacerrada; Ana Rojo-Sebastián; Lluisa Rubio; Sara Ortega-Cubero; Pau Pastor; Marisol Calleja; José Francisco Plaza-Nieto; Belén Pilo-de-la-Fuente; Margarita Arroyo-Solera; Esteban García-Albea; José A G Agúndez
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more
  2 in total

1.  The Role of BTBD9 in the Cerebellum, Sleep-like Behaviors and the Restless Legs Syndrome.

Authors:  Shangru Lyu; Hong Xing; Mark P DeAndrade; Pablo D Perez; Fumiaki Yokoi; Marcelo Febo; Arthur S Walters; Yuqing Li
Journal:  Neuroscience       Date:  2020-05-22       Impact factor: 3.590

2.  Consensus guidelines on the construct validity of rodent models of restless legs syndrome.

Authors:  Aaro V Salminen; Stefan Clemens; Diego García-Borreguero; Imad Ghorayeb; Yuqing Li; Mauro Manconi; William Ondo; David Rye; Jerome M Siegel; Alessandro Silvani; John W Winkelman; Richard P Allen; Sergi Ferré
Journal:  Dis Model Mech       Date:  2022-08-10       Impact factor: 5.732

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.